Anti-AIDS agents--XXVII. Synthesis and anti-HIV activity of betulinic acid and dihydrobetulinic acid derivatives (Q41066416)

26 September 2017

Anti-AIDS agents--XXVII. Synthesis and anti-HIV activity of betulinic acid and dihydrobetulinic acid derivatives (English)

1 reference

26 September 2017

0 references

0 references

dihydrobetulinic acid

1 reference

ChEBI release 2020-05-28

Hashimoto F

1

1 reference

26 September 2017

Kashiwada Y

2

1 reference

26 September 2017

Cosentino LM

3

1 reference

26 September 2017

Chen CH

4

1 reference

26 September 2017

Garrett PE

5

1 reference

26 September 2017

Lee KH

6

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 December 1997

1 reference

Bioorganic & Medicinal Chemistry

26 September 2017

1 reference

26 September 2017

5

1 reference

26 September 2017

12

1 reference

26 September 2017

2133-2143

1 reference

Synthesis and anti-HIV evaluation of D4T and D4T 5'-monophosphate prodrugs

26 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900158-2

7 January 2021

Natural occurrence of drug resistance mutations in the reverse transcriptase of human immunodeficiency virus type 1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900158-2

7 January 2021

Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900158-2

7 January 2021

3-Tetrahydrofuran and pyran urethanes as high-affinity P2-ligands for HIV-1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900158-2

7 January 2021

HIV-1 protease inhibitory activity of L-694,746, a novel metabolite of L-689,502

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900158-2

7 January 2021

Symmetry-based inhibitors of HIV protease. Structure-activity studies of acylated 2,4-diamino-1,5-diphenyl-3-hydroxypentane and 2,5-diamino-1,6-diphenylhexane-3,4-diol

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900158-2

7 January 2021

Differential effects of a hydrophobic tripeptide on human immunodeficiency virus type 1 (HIV-1)-induced syncytium formation and viral infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900158-2

7 January 2021

Inhibition of human immunodeficiency virus type-1 integrase by curcumin

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900158-2

7 January 2021

Anti-AIDS agents, 11. Betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoids

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900158-2

7 January 2021

Anti-AIDS agents. 15. Synthesis and anti-HIV activity of dihydroseselins and related analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900158-2

7 January 2021

Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900158-2

7 January 2021

Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900158-2

7 January 2021

10.1016/S0968-0896(97)00158-2

Identifiers

DOI

1 reference

26 September 2017

1 reference